Spots Global Cancer Trial Database for One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population
Official Title: An Open-label, Multi-centre, Randomised, Parallel-group Trial, Comparing Efficacy and Safety of Degarelix One-month Dosing Regimen With Goserelin in Chinese Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Study ID: NCT01744366
Conditions
Study Description
Brief Summary: One month degarelix/comparator treatment for prostate cancer in Chinese population
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Cancer Institute & Hospital. Chinese Academy of Medical Sciences, Beijing, Beijing, China
Affiliated Southwest Hospital of 3rd Military Medical University of People's Liberation Army, Chongqing, Chongqing, China
1st Afilliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong, China
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
2nd.Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi'an, Shanxi, China
1st Hospital Affiliated to Zhejiang University Medical School, Hangzhou, Zhejiang, China
Beijing Hospital of Ministry of Health, Beijing, , China
Peking Union Hospital, Beijing, , China
Peking University 3rd Hospital, Beijing, , China
Peking University People's Hospital, Beijing, , China
1st Hospital of Jilin University, Changchun, , China
Hunan Cancer Hospital, Changsha, , China
Hunan Province People's Hospital, Changsha, , China
People's Hospital of Sichuan, Chengdu, , China
2nd Hospital Affiliated to Zhejiang University Medical School, Hangzhou, , China
1st Hospital of Lanzhou University, Lanzhou, , China
1st Affiliated Hospital of Nanchang University, Nanchang, , China
1st Affiliated Hospital of Nanjing Medical University, Nanjing, , China
Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, , China
Fudan University Shanghai Cancer Center, Shanghai, , China
Huashan Hospital of Fudan University, Shanghai, , China
Shanghai 5th People's Hospital affilicated to Fudan University, Shanghai, , China
Shanghai Changhai Hospital, Shanghai, , China
1st Hospital Affiliated to China Medical University, Shenyang, , China
2nd Hospital Affiliated to Suzhou University, Suzhou, , China
2nd Hospital of Tianjin Medical University, Tianjin, , China
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, , China
Zhongnan Hospital of Wuhan University, Wuhan, , China
1st People's Hospital of Wuxi, Wuxi, , China
Contact Details
Name: Clinical Development Support
Affiliation: Ferring Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
